Evidence map›Paper›PMID 38755733›Full record

ReviewJournal of cannabis research2024

Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer.

Husam A ALSalamat, Sara Feras Abuarab, Hazem Mohamed Salamah, Anas Hasan Ishqair, Mohammad Fuad Dwikat, Anas Zakarya Nourelden, Aseel N Qandil, Yasmeen Barakat, Muna Barakat

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of cannabis research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Husam A ALSalamatDepartment of Basic Medical Sciences, Faculty of Medicine, Al-Balqa Applied University, Al-Salt, 19117, Jordan.
Sara Feras AbuarabDepartment of Clinical Pharmacy and Therapeutics, School of Pharmacy, Applied Science Private University, Amman, 541350, Jordan.
Hazem Mohamed SalamahInternational Medical Research Association (IMedRA), Cairo, Egypt.
Anas Hasan IshqairInternational Medical Research Association (IMedRA), Cairo, Egypt.
Mohammad Fuad DwikatInternational Medical Research Association (IMedRA), Cairo, Egypt.
Anas Zakarya NoureldenInternational Medical Research Association (IMedRA), Cairo, Egypt.
Aseel N QandilDepartment of Basic Medical Sciences, Faculty of Medicine, Al-Balqa Applied University, Al-Salt, 19117, Jordan.
Yasmeen BarakatDepartment of Clinical Pharmacy and Therapeutics, School of Pharmacy, Applied Science Private University, Amman, 541350, Jordan.
Muna BarakatDepartment of Clinical Pharmacy and Therapeutics, School of Pharmacy, Applied Science Private University, Amman, 541350, Jordan. M_barakat@asu.edu.jo.ORCID http://orcid.org/0000-0002-7966-1172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer comes in second place on the list of causes of death worldwide. In 2018, the 5-year prevalence of breast cancer (BC), prostate cancer (PC), and colorectal cancer (CRC) were 30%, 12.3%, and 10.9%, respectively. Cannabinoids are chemicals derived from the Cannabis sativa plant; the most investigated cannabinoids are cannabinol, delta 9-tetrahydrocannabinol (Δ

Indexed as

Anti-cancerBreastCancerCannabinoidsCannabisColorectalProstate

Identifiers

PMID38755733
PMCPMC11097556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.